Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment

R Cairns, I Papandreou, N Denko - Molecular Cancer Research, 2006 - AACR
It is widely recognized that the vasculature of the tumor is inadequate to meet the demands
of the growing mass. The malformed vasculature is at least in part responsible for regions of …

Molecularly targeted therapy for malignant glioma

S Sathornsumetee, DA Reardon, A Desjardins… - Cancer, 2007 - Wiley Online Library
Malignant gliomas are relatively uncommon but lethal cancers. Despite recent research
efforts in cancer therapy, the prognosis of patients with malignant gliomas has remained …

Thematic review series: lipid posttranslational modifications. Farnesyl transferase inhibitors

AD Basso, P Kirschmeier, WR Bishop - Journal of lipid research, 2006 - ASBMB
Some proteins undergo posttranslational modification by the addition of an isoprenyl lipid
(farnesyl-or geranylgeranyl-isoprenoid) to a cysteine residue proximal to the C terminus …

Rho GTPases as therapeutic targets in cancer

GA Cardama, N González… - International …, 2017 - spandidos-publications.com
Rho GTPases are key molecular switches controlling the transduction of external signals to
cytoplasmic and nuclear effectors. In the last few years, the development of genetic and …

FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST

Y Zheng, Y Xia, D Hawke, M Halle, ML Tremblay… - Molecular cell, 2009 - cell.com
Activated Ras has been found in many types of cancer. However, the mechanism underlying
Ras-promoted tumor metastasis remains unclear. We demonstrate here that activated Ras …

The RAS signal transduction pathway and its role in radiation sensitivity

W Gillies McKenna, RJ Muschel, AK Gupta, SM Hahn… - Oncogene, 2003 - nature.com
RAS has been shown to increase radiation resistance. Upstream and downstream pathways
from RAS could thus be targets for manipulation of radiosensitivity. EGFR expression and …

The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review

NB Pepper, W Stummer, HT Eich - Strahlentherapie und Onkologie, 2022 - Springer
Background Glioblastoma is the most common malignant brain tumor in human adults.
Despite several improvements in resective as well as adjuvant therapy over the last …

αvβ3 and αvβ5 integrins control glioma cell response to ionising radiation through ILK and RhoB

S Monferran, N Skuli, C Delmas, G Favre… - … Journal of Cancer, 2008 - Wiley Online Library
Integrins are extracellular matrix receptors involved in tumour invasion and angiogenesis.
Although there is evidence that inhibiting integrins might enhance the efficiency of …

αvβ3vβ5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma

N Skuli, S Monferran, C Delmas, G Favre, J Bonnet… - Cancer Research, 2009 - AACR
The presence of hypoxic areas in glioblastoma is an important determinant in tumor
response to therapy and, in particular, to radiotherapy. Here we have explored the …

Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1

MD Naidu, JM Mason, RV Pica, H Fung… - Journal of radiation …, 2010 - academic.oup.com
Since radiation therapy remains a primary treatment modality for gliomas, the
radioresistance of glioma cells and targets to modify their radiation tolerance are of …